Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

OBJECTIVE: Thiazolidinediones are used to treat type 2 diabetes. Their use has been associated with peripheral edema and congestive heart failure—outcomes that may have a genetic etiology. RESEARCH DESIGN AND METHODS: We genotyped 4,197 participants of the multiethnic DREAM (Diabetes REduction Asses...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bailey, Swneke D., Xie, Changchun, Do, Ron, Montpetit, Alexandre, Diaz, Rafael, Mohan, Viswanathan, Keavney, Bernard, Yusuf, Salim, Gerstein, Hertzel C., Engert, James C., Anand, Sonia
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2010
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2945168/
https://ncbi.nlm.nih.gov/pubmed/20628086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0452
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires